We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+9.67%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$98.6B
AUM Growth
+$9.82B
Cap. Flow
+$3.18B
Cap. Flow %
3.23%
Top 10 Hldgs %
34.51%
Holding
3,532
New
899
Increased
935
Reduced
953
Closed
698

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$3.93B
2
MSFT icon
Microsoft
MSFT
+$556M
3
COR icon
Cencora
COR
+$492M
4
NFLX icon
Netflix
NFLX
+$452M
5
BAC icon
Bank of America
BAC
+$411M

Sector Composition

Rank Sector Weight
1 Technology 20.19%
2 Consumer Discretionary 12.64%
3 Healthcare 9.35%
4 Financials 8.34%
5 Communication Services 6.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARBE icon
2626
Arbe Robotics
ARBE
$73.3M
$104K ﹤0.01%
+63,297
New +$92.3K
NTNX icon
2627
PUT
Nutanix
NTNX
$16.1B
$104K ﹤0.01%
+1,400
New +$103K
LVO icon
2628
LiveOne
LVO
$59.8M
$103K ﹤0.01%
25,045
+1,901
+8% +$11.8K
STRO icon
2629
Sutro Biopharma
STRO
$386M
$103K ﹤0.01%
11,844
-11,599
-49% -$98.7K
INTT icon
2630
inTEST
INTT
$143M
$103K ﹤0.01%
+13,155
New +$96.5K
WVE icon
2631
Wave Life Sciences
WVE
$1.12B
$102K ﹤0.01%
14,000
-10,828
-44% -$87.6K
ANET icon
2632
PUT
Arista Networks
ANET
$199B
$102K ﹤0.01%
+700
New +$90.1K
TUSK icon
2633
Mammoth Energy Services
TUSK
$122M
$102K ﹤0.01%
44,517
-12,919
-22% -$31.8K
ALM
2634
Almonty Industries
ALM
$3.11B
$101K ﹤0.01%
+16,752
New +$76.2K
TEVA icon
2635
CALL
Teva Pharmaceuticals
TEVA
$40.4B
$101K ﹤0.01%
+5,000
New +$87.8K
STKE
2636
Sol Strategies Inc
STKE
$38.8M
$99.9K ﹤0.01%
+23,013
New +$139K
AAOI icon
2637
PUT
Applied Optoelectronics
AAOI
$6.14B
$98.5K ﹤0.01%
+3,800
New +$97.2K
RCL icon
2638
CALL
Royal Caribbean
RCL
$86.5B
$97.1K ﹤0.01%
+300
New +$100K
RBLX icon
2639
CALL
Roblox
RBLX
$35.9B
$97K ﹤0.01%
+700
New +$87K
EL icon
2640
PUT
Estee Lauder
EL
$30.4B
$96.9K ﹤0.01%
+1,100
New +$98K
LDOS icon
2641
PUT
Leidos
LDOS
$14.4B
$94.5K ﹤0.01%
+500
New +$87K
STT icon
2642
PUT
State Street
STT
$48.4B
$92.8K ﹤0.01%
+800
New +$89.3K
SNBR
2643
DELISTED
Sleep Number
SNBR
$92.2K ﹤0.01%
+13,133
New +$115K
BNKK
2644
Bonk Inc
BNKK
$7.7M
$90K ﹤0.01%
+9,523
New +$174K
NVS icon
2645
PUT
Novartis
NVS
$302B
$89.8K ﹤0.01%
+700
New +$85.4K
LYFT icon
2646
CALL
Lyft
LYFT
$5.86B
$88K ﹤0.01%
+4,000
New +$66.9K
TOI icon
2647
The Oncology Institute
TOI
$477M
$87.8K ﹤0.01%
25,164
-1,451,782
-98% -$4.97M
FLYY
2648
DELISTED
Spirit Aviation Holdings, Inc.
FLYY
$87.8K ﹤0.01%
230,994
-81,300
-26% -$288K
CNTB
2649
Connect Biopharma Holdings
CNTB
$129M
$85.9K ﹤0.01%
+58,031
New +$103K
TCRX icon
2650
TScan Therapeutics
TCRX
$48.5M
$84.9K ﹤0.01%
46,630
-7,048
-13% -$12.5K

Similar funds

Marshall Wace's Q3 2025 Portfolio in Review

As of Q3 2025, Marshall Wace held 3,532 positions worth $98.6B, up 11% from $88.8B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Marshall Wace deployed $3.18B of net new capital in Q3 2025, opening 899 new positions and adding to 935 existing holdings. Its largest new stake was Texas Instruments: 1,537,539 shares worth $282M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $636M trimmed.

  • Marshall Wace's largest Q3 2025 buy was Texas Instruments: 1,537,539 shares worth $282M.
  • Marshall Wace added most to iShares Core S&P 500 ETF in Q3 2025, an estimated $3.93B increase.
  • Marshall Wace's biggest Q3 2025 reduction was Alphabet (Google) Class A, cutting an estimated $636M.
  • Marshall Wace fully exited AT&T in Q3 2025, selling an estimated $235M.
  • Marshall Wace's ten largest holdings make up 35% of its $98.6B portfolio in Q3 2025.
  • Marshall Wace opened 899 new positions and closed 698 in Q3 2025.
  • Marshall Wace's portfolio value rose 11% quarter-over-quarter to $98.6B.

Based on Marshall Wace's 13F filing for Q3 2025, filed 13 Nov 2025.